Literature DB >> 2835688

Local modulation of adrenal catecholamines release by beta-2 adrenoceptors in the anaesthetized dog.

S Foucart1, R Nadeau, J de Champlain.   

Abstract

The release of adrenal catecholamines into the adrenal vein elicited by splanchnic nerve stimulation, was evaluated in the presence of a beta-adrenoceptor agonist and both beta-1 and beta-2 adrenoceptor antagonists in anaesthetized and vagotomized dogs. Stimulations (0.5 V pulses of 2 ms duration for 3 min at 1 Hz) were applied before and after the i.v. infusion of the beta-adrenoceptor agonist, isoproterenol (0.1 microgram/kg/min). While maintaining the infusion of isoproterenol, either ICI 118551 (0.3 mg/kg), a selective beta-2 adrenoceptor antagonist, or 204-155 (0.2 mg/kg), a selective beta-1 adrenoceptor antagonist (Sandoz Co., Dorval, PQ, Canada), were injected intravenously and the stimulation was repeated. The results show that isoproterenol increased significantly both pre-stimulation basal levels and the stimulated release of catecholamines. These potentiated responses were significantly reversed by ICI 118551, but not by 204-155. These results suggest that the release of adrenal catecholamines is locally modulated by a positive feedback mechanism through activation of beta-2 adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835688     DOI: 10.1007/BF00169473

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  The secretion of adrenaline from the perfused suprarenal gland.

Authors:  E Bülbring; J H Burn; F J De Elio
Journal:  J Physiol       Date:  1948-03-15       Impact factor: 5.182

Review 2.  A possible role of epinephrine in the development of hypertension.

Authors:  H Majewski; M J Rand
Journal:  Med Res Rev       Date:  1986 Oct-Dec       Impact factor: 12.944

3.  Evidence that ICI 118, 551 is a potent, highly Beta 2-selective adrenoceptor antagonist and can be used to characterize Beta-adrenoceptor populations in tissues.

Authors:  S R O'Donnell; J C Wanstall
Journal:  Life Sci       Date:  1980-08-25       Impact factor: 5.037

4.  Failure of beta-adrenergic receptors to modulate adrenal medullary secretion.

Authors:  M L Michener; M J Peach
Journal:  Biochem Pharmacol       Date:  1984-06-01       Impact factor: 5.858

5.  The release of catecholamines from the adrenal medulla and its modulation by alpha 2-adrenoceptors in the anaesthetized dog.

Authors:  S Foucart; R Nadeau; J de Champlain
Journal:  Can J Physiol Pharmacol       Date:  1987-04       Impact factor: 2.273

6.  Catecholamine secretion from the rabbit adrenal gland is not modulated by a mechanism involving beta-adrenoceptors.

Authors:  A R Collett; M J Rand; D F Story
Journal:  Arch Int Pharmacodyn Ther       Date:  1984-05

7.  Facilitation of secretion of catecholamines from rat and guinea-pig adrenal glands in potassium-free medium or after ouabain.

Authors:  A R Wakade
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

8.  ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.

Authors:  J A Nathanson
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

Review 9.  Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors.

Authors:  H Majewski
Journal:  J Auton Pharmacol       Date:  1983-03

Review 10.  Presynaptic beta-adrenoceptors.

Authors:  Y Misu; T Kubo
Journal:  Med Res Rev       Date:  1986 Apr-Jun       Impact factor: 12.944

View more
  2 in total

1.  Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure.

Authors:  G Rengo; A Lymperopoulos; C Zincarelli; Gd Femminella; D Liccardo; G Pagano; C de Lucia; A Cannavo; P Gargiulo; N Ferrara; P Perrone Filardi; Wj Koch; D Leosco
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes.

Authors:  Gaetano Santulli; Guido Iaccarino
Journal:  Immun Ageing       Date:  2013-03-15       Impact factor: 6.400

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.